Cheng Su

Cheng Su is an accomplished statistician with extensive experience in the pharmaceutical industry. Currently serving as Executive Director of Data Science at BioMarin Pharmaceutical Inc. since January 2019, Cheng Su leads the departmental AI initiative and is responsible for a bi-weekly AI forum. Previously, Cheng Su held the role of Director of Biostatistics in Early Clinical Development at Amgen, overseeing statistical support for first-in-human clinical trials and developing centralized statistical monitoring tools. Additionally, Cheng Su directed biostatistics for Research and Translational Sciences at Amgen, fostering a high-functioning team to support diverse research initiatives. Earlier experience includes roles as Manager of Research Biostatistics, Principal Statistician, and Senior Statistician at Roche Palo Alto, where statistical leadership was provided in research discovery. Cheng Su earned a Ph.D. in Statistics from North Carolina State University and a BS in Industrial Trade and Computer Science from Shanghai Jiao Tong University.